These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 27806260)
1. Crystal Structure of the Complex of Human FasL and Its Decoy Receptor DcR3. Liu W; Ramagopal U; Cheng H; Bonanno JB; Toro R; Bhosle R; Zhan C; Almo SC Structure; 2016 Nov; 24(11):2016-2023. PubMed ID: 27806260 [TBL] [Abstract][Full Text] [Related]
2. Decoy strategies: the structure of TL1A:DcR3 complex. Zhan C; Patskovsky Y; Yan Q; Li Z; Ramagopal U; Cheng H; Brenowitz M; Hui X; Nathenson SG; Almo SC Structure; 2011 Feb; 19(2):162-71. PubMed ID: 21300286 [TBL] [Abstract][Full Text] [Related]
3. Decoy receptor 3 regulates the expression of various genes in rheumatoid arthritis synovial fibroblasts. Fukuda K; Miura Y; Maeda T; Takahashi M; Hayashi S; Kurosaka M Int J Mol Med; 2013 Oct; 32(4):910-6. PubMed ID: 23912906 [TBL] [Abstract][Full Text] [Related]
4. Mechanistic basis for functional promiscuity in the TNF and TNF receptor superfamilies: structure of the LIGHT:DcR3 assembly. Liu W; Zhan C; Cheng H; Kumar PR; Bonanno JB; Nathenson SG; Almo SC Structure; 2014 Sep; 22(9):1252-1262. PubMed ID: 25087510 [TBL] [Abstract][Full Text] [Related]
5. DcR3 promotes hepatoma cell migration by downregulating E-cadherin expression. Zhang H; Chen X; Li D; Cui L; Li X; Ye X; Wan X Oncol Rep; 2017 Jul; 38(1):377-383. PubMed ID: 28560426 [TBL] [Abstract][Full Text] [Related]
6. Decoy receptor 3 (DcR3) is proteolytically processed to a metabolic fragment having differential activities against Fas ligand and LIGHT. Wroblewski VJ; Witcher DR; Becker GW; Davis KA; Dou S; Micanovic R; Newton CM; Noblitt TW; Richardson JM; Song HY; Hale JE Biochem Pharmacol; 2003 Feb; 65(4):657-67. PubMed ID: 12566095 [TBL] [Abstract][Full Text] [Related]
7. Idiopathic pulmonary fibrosis fibroblasts become resistant to Fas ligand-dependent apoptosis via the alteration of decoy receptor 3. Im J; Kim K; Hergert P; Nho RS J Pathol; 2016 Sep; 240(1):25-37. PubMed ID: 27218286 [TBL] [Abstract][Full Text] [Related]
8. DcR3-TL1A signalling inhibits cytokine-induced proliferation of rheumatoid synovial fibroblasts. Takahashi M; Miura Y; Hayashi S; Tateishi K; Fukuda K; Kurosaka M Int J Mol Med; 2011 Sep; 28(3):423-7. PubMed ID: 21537832 [TBL] [Abstract][Full Text] [Related]
9. Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis. Hayashi S; Miura Y; Nishiyama T; Mitani M; Tateishi K; Sakai Y; Hashiramoto A; Kurosaka M; Shiozawa S; Doita M Arthritis Rheum; 2007 Apr; 56(4):1067-75. PubMed ID: 17393415 [TBL] [Abstract][Full Text] [Related]
10. Decoy receptor 3: a pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer. Lin WW; Hsieh SL Biochem Pharmacol; 2011 Apr; 81(7):838-47. PubMed ID: 21295012 [TBL] [Abstract][Full Text] [Related]
11. Silencing of decoy receptor 3 (DcR3) expression by siRNA in pancreatic carcinoma cells induces Fas ligand-mediated apoptosis in vitro and in vivo. Zhou J; Song S; He S; Wang Z; Zhang B; Li D; Zhu D Int J Mol Med; 2013 Sep; 32(3):653-60. PubMed ID: 23846297 [TBL] [Abstract][Full Text] [Related]
12. Correlation between expression of DcR3 on tumor cells and sensitivity to FasL. Li W; Zhang C; Chen C; Zhuang G Cell Mol Immunol; 2007 Dec; 4(6):455-60. PubMed ID: 18163957 [TBL] [Abstract][Full Text] [Related]
13. Decoy receptor 3 suppresses FasL-induced apoptosis via ERK1/2 activation in pancreatic cancer cells. Zhang Y; Li D; Zhao X; Song S; Zhang L; Zhu D; Wang Z; Chen X; Zhou J Biochem Biophys Res Commun; 2015 Aug; 463(4):1144-51. PubMed ID: 26102031 [TBL] [Abstract][Full Text] [Related]
14. Ascites from epithelial ovarian cancer contain high levels of functional decoy receptor 3 (DcR3) and is associated with platinum resistance. Connor JP; Felder M Gynecol Oncol; 2008 Nov; 111(2):330-5. PubMed ID: 18723214 [TBL] [Abstract][Full Text] [Related]
15. Serum and synovial fluid levels of tumor necrosis factor-like ligand 1A and decoy receptor 3 in rheumatoid arthritis. Xiu Z; Shen H; Tian Y; Xia L; Lu J Cytokine; 2015 Apr; 72(2):185-9. PubMed ID: 25647275 [TBL] [Abstract][Full Text] [Related]
16. DcR3 protects islet beta cells from apoptosis through modulating Adcyap1 and Bank1 expression. Han B; Wu J J Immunol; 2009 Dec; 183(12):8157-66. PubMed ID: 20007581 [TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of overexpression of the decoy receptor for Fas ligand (DcR3) in patients with gastric carcinomas. Takahama Y; Yamada Y; Emoto K; Fujimoto H; Takayama T; Ueno M; Uchida H; Hirao S; Mizuno T; Nakajima Y Gastric Cancer; 2002; 5(2):61-8. PubMed ID: 12111580 [TBL] [Abstract][Full Text] [Related]
18. High intestinal and systemic levels of decoy receptor 3 (DcR3) and its ligand TL1A in active ulcerative colitis. Bamias G; Kaltsa G; Siakavellas SI; Papaxoinis K; Zampeli E; Michopoulos S; Zouboulis-Vafiadis I; Ladas SD Clin Immunol; 2010 Nov; 137(2):242-9. PubMed ID: 20675196 [TBL] [Abstract][Full Text] [Related]
19. Decoy receptor 3 expression in AsPC-1 human pancreatic adenocarcinoma cells via the phosphatidylinositol 3-kinase-, Akt-, and NF-kappa B-dependent pathway. Chen PH; Yang CR J Immunol; 2008 Dec; 181(12):8441-9. PubMed ID: 19050262 [TBL] [Abstract][Full Text] [Related]